Advent International to Acquire PatientPoint

Highlighting the growing role of point-of-care media in omnichannel

solli
25th August 2025

Advent International has announced plans to acquire PatientPoint, which operates a large digital point-of-care (POC) engagement network in the United States. PatientPoint’s platform spans more than 30,000 physician offices and reaches approximately 125,000 healthcare providers, positioning itself as a central platform for patient education, HCP engagement, and measurable media activation.

Why this matters for pharma media

Point-of-care as a media channel
POC environments have become a key focus area for pharmaceutical marketing due to their influence on treatment discussions and prescribing behavior. With Advent’s backing, PatientPoint is expected to expand its scale and capabilities, seeking to further establish POC media as a core component of broader omnichannel planning alongside channels such as connected TV, social, and digital video.

Data-driven personalization
PatientPoint has emphasized analytics-based targeting and measurement in recent years. The acquisition could accelerate this approach, offering pharmaceutical companies opportunities to deliver personalized, contextually relevant messaging at the point of care. This evolution also raises industry-wide expectations for standardized performance metrics and clearer ROI benchmarks relative to other digital investments.

Integration into care workflows
Unlike traditional awareness media, POC messaging is embedded directly within healthcare interactions. Advent’s investment reflects a broader movement toward treating media as an extension of clinical communication.

solli’s final thought

Advent’s move to acquire PatientPoint is more than a financial deal—it’s a signal of the rising strategic importance of point-of-care media within pharma marketing. For brands, the challenge and opportunity will be to integrate these environments into omnichannel ecosystems in ways that are compliant, patient-centric, and measurably effective.


Read the full press release HERE

Most Popular Content